These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15512970)

  • 1. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.
    Williams DL; Fitzmaurice T; Lay L; Forster K; Hefford J; Budge C; Blackmore K; Robinson JC; Field HF
    Curr Eye Res; 2004; 29(2-3):215-8. PubMed ID: 15512970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
    Hussein IT; Menashy RV; Field HJ
    Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
    Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
    Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations.
    Williams DL; Robinson JC; Lay E; Field H
    Vet Rec; 2005 Aug; 157(9):254-7. PubMed ID: 16127135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
    Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
    Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds.
    Hussein IT; Field HJ
    J Virol Methods; 2008 Sep; 152(1-2):85-90. PubMed ID: 18597862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites.
    Groth AD; Contreras MT; Kado-Fong HK; Nguyen KQ; Thomasy SM; Maggs DJ
    Vet Ophthalmol; 2014 Jul; 17(4):268-74. PubMed ID: 24112415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
    Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
    Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
    Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
    Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
    J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis.
    Panda A; Das GK; Khokhar S; Rao V
    Can J Ophthalmol; 1995 Aug; 30(5):256-8. PubMed ID: 8529160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
    Kaufman HE; Haw WH
    Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
    Hussein IT; Miguel RN; Tiley LS; Field HJ
    Arch Virol; 2008; 153(3):495-505. PubMed ID: 18196203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.